MedPage Today on MSN4d
Active Surveillance May Have a Role in Esophageal CancerActive surveillance (AS) following a complete clinical response to neoadjuvant chemoradiotherapy was noninferior to standard ...
Steven Richardson, after being diagnosed with stage 4 cancer of the esophagus in 2023, would have to split his focus between ...
A multi-site study, backed by an $8 million NIH grant, will evaluate the effectiveness of Lucid Diagnostics' EsoCheck and ...
Ken Kato, MD, PhD, and Harry H. Yoon, MD, MHS, discussed the recent FDA approval of tislelizumab in the first line for ...
Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced that ...
Over the past year, the Rapid City Rush have had their share of battles when it comes to cancer. Which is why their Rush ...
Disorders like esophageal cancer and gastroesophageal reflux disease are difficult to treat without properly understanding the esophagus’s mechanical properties. The findings establish a baseline for ...
Harry H. Yoon, MD, MHS, discusses tislelizumab and platinum-containing chemotherapy in unresectable or metastatic esophageal squamous cell carcinoma whose tumors express PD-L1 at a level of 1 or ...
MONROE, La. (KNOE) - The Monroe Fire Department has finished its three-day esophageal cancer screening event for its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback